Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -41.40%781.62M | -33.38%779.7M | -25.79%1.08B | -5.56%1.14B | 36.23%1.33B | -21.98%1.17B | 15.99%1.45B | -40.11%1.21B | 18.61%979.05M | 162.41%1.5B |
| Transactional financial assets | ---- | ---- | ---- | ---- | --4.23M | ---- | ---- | ---- | ---- | ---- |
| Notes receivable and accounts receivable | -6.85%107.51M | -38.57%92.89M | -16.98%113.12M | -37.23%76.56M | 240.78%115.42M | 446.54%151.22M | 233.50%136.27M | 157.62%121.97M | -27.86%33.87M | -49.55%27.67M |
| -Accounts receivable | -6.85%107.51M | -38.57%92.89M | -16.98%113.12M | -37.23%76.56M | 240.78%115.42M | 446.54%151.22M | 233.50%136.27M | 157.62%121.97M | -27.86%33.87M | -49.55%27.67M |
| Other receivables (including interest and dividends) | 16.32%101.6M | 11.79%98.07M | 13.26%101.14M | 0.87%93.28M | -11.87%87.34M | -10.43%87.73M | -7.03%89.29M | -11.91%92.47M | -4.51%99.11M | -7.66%97.94M |
| -Other receivable | ---- | ---- | ---- | 0.87%93.28M | ---- | -10.43%87.73M | ---- | -11.91%92.47M | ---- | -7.66%97.94M |
| Advance payment | 36.15%103.12M | 25.67%91.52M | -28.41%70.65M | -60.30%66.67M | -33.61%75.74M | -39.30%72.83M | -30.45%98.68M | 19.44%167.91M | -47.50%114.08M | 15.02%119.98M |
| Inventories | -18.04%1.68B | -16.14%1.74B | 34.37%2.4B | 18.17%2.21B | 3.97%2.05B | 10.76%2.07B | -14.32%1.78B | 5.25%1.87B | 14.00%1.97B | 20.75%1.87B |
| Other current assets | -27.57%38.5M | -21.36%41.49M | 32.52%51.42M | 42.20%55.49M | 21.08%53.15M | 22.36%52.76M | -36.76%38.8M | -32.34%39.02M | -15.54%43.89M | -10.59%43.12M |
| Total current assets | -24.38%2.81B | -21.22%2.84B | 5.91%3.81B | 4.12%3.64B | 14.73%3.72B | -1.43%3.61B | -2.06%3.6B | -15.52%3.5B | 8.97%3.24B | 50.31%3.66B |
| Non Current assets | ||||||||||
| Other non-current financial assets | -24.77%303.78K | -24.77%303.78K | 0.00%403.78K | 0.00%403.78K | 0.00%403.78K | 0.00%403.78K | 0.00%403.78K | 0.00%403.78K | 0.00%403.78K | 0.00%403.78K |
| Investment real estate | -4.02%36.75M | -3.98%37.14M | -3.94%37.52M | -3.90%37.9M | -3.86%38.29M | -3.83%38.67M | -3.79%39.06M | -3.75%39.44M | -3.72%39.83M | -3.68%40.21M |
| Long-term equity investment | 0.73%359.88M | 0.13%359.14M | -1.40%356.98M | -2.17%356.41M | -2.58%357.26M | -2.51%358.68M | -0.62%362.03M | 8.81%364.32M | 9.13%366.72M | 9.29%367.92M |
| Fixed assets | ---- | ---- | ---- | 6.31%1.87B | ---- | 14.53%1.95B | ---- | 21.73%1.76B | ---- | 29.44%1.7B |
| Constru in process | ---- | ---- | ---- | -81.11%54.36M | ---- | -86.82%44.14M | ---- | -39.67%287.77M | ---- | -39.63%334.88M |
| Productive biological assets | -11.08%685.24M | -11.95%738.7M | -15.41%731.62M | -18.92%719.35M | -11.38%770.64M | -11.75%838.98M | 0.53%864.9M | 7.63%887.23M | 5.69%869.62M | 13.09%950.71M |
| Intangible assets | -3.30%175.86M | -3.25%177.61M | -3.08%178.78M | 12.56%180.4M | 12.39%181.87M | 12.35%183.58M | 19.25%184.46M | -2.55%160.27M | -1.49%161.81M | -1.26%163.4M |
| Long deferred expense | -13.03%25.75M | -10.20%28.37M | -4.10%27.56M | -6.99%27.84M | -7.59%29.61M | -0.01%31.6M | -6.54%28.74M | -6.07%29.93M | -7.56%32.04M | -11.54%31.6M |
| Deferred tax assets | 44.07%24.97M | 49.14%23.25M | 38.55%17.72M | 21.73%16.98M | 45.82%17.33M | 62.59%15.59M | 31.13%12.79M | 40.04%13.95M | 27.20%11.88M | 5.27%9.59M |
| Usufruct assets | -11.42%4.56B | -11.31%4.68B | -8.18%4.87B | -5.17%5B | -2.27%5.15B | -1.66%5.28B | 6.03%5.3B | 5.90%5.27B | 16.84%5.27B | 24.43%5.37B |
| Other non current assets | 23.23%13.9M | 120.10%16.7M | -28.13%16.55M | -68.60%11.32M | -70.33%11.28M | -70.40%7.59M | -58.13%23.03M | -34.42%36.04M | -29.63%38.02M | -52.38%25.63M |
| Total non current assets | -9.29%7.73B | -9.28%7.94B | -7.92%8.13B | -6.50%8.28B | -3.79%8.52B | -2.74%8.75B | 4.04%8.83B | 5.84%8.85B | 12.76%8.86B | 17.31%9B |
| Total assets | -13.88%10.54B | -12.77%10.78B | -3.91%11.94B | -3.49%11.92B | 1.18%12.24B | -2.36%12.36B | 2.20%12.42B | -1.23%12.35B | 11.72%12.1B | 25.26%12.66B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -8.73%880.1M | 1.95%984.81M | -23.99%897.01M | -53.06%622.29M | -27.69%964.24M | -47.94%966.01M | -12.31%1.18B | 1.90%1.33B | 47.04%1.33B | 186.85%1.86B |
| Notes payable and accounts payable | 15.30%759.94M | 21.07%837.34M | 24.47%765.08M | 3.34%714.76M | -9.66%659.07M | 8.22%691.6M | 7.27%614.66M | 27.26%691.64M | 31.01%729.58M | 69.03%639.07M |
| -Notes payable | 132.75%183.05M | 197.60%225.99M | 1.03%90.75M | -25.36%80.77M | -32.24%78.65M | -44.32%75.94M | 38.96%89.82M | --108.21M | --116.07M | --136.39M |
| -Accounts payable | -0.61%576.89M | -0.70%611.35M | 28.48%674.33M | 8.67%633.99M | -5.39%580.43M | 22.48%615.67M | 3.24%524.84M | 7.35%583.43M | 10.17%613.51M | 32.95%502.68M |
| Contract liabilities | 3.05%35.33M | -17.66%31.74M | -30.69%44.01M | 2.30%52.95M | -56.99%34.28M | -22.07%38.55M | -16.78%63.49M | -20.12%51.76M | 60.36%79.7M | 30.47%49.46M |
| Advance receipts | ---- | ---- | ---- | ---- | -74.68%1.31K | -72.53%1.42K | --1.65K | --7.55K | --5.18K | --5.18K |
| Salaries payable | 23.20%130.84M | 5.42%111.77M | 18.87%107.29M | 20.70%107.86M | 16.07%106.2M | 9.52%106.02M | 10.20%90.25M | 10.05%89.37M | 16.36%91.5M | -4.94%96.8M |
| Taxs payable | -13.35%7.77M | -13.80%10.63M | -19.18%7.3M | -18.79%7.13M | -2.08%8.96M | 29.95%12.34M | 35.31%9.03M | 27.72%8.77M | 9.26%9.15M | -14.05%9.49M |
| Other payable (including interest and dividends) | 19.08%328.44M | 12.57%310.66M | 13.44%285.88M | -4.45%269.29M | -2.12%275.82M | 13.55%275.97M | 8.31%252M | -10.49%281.84M | -38.09%281.79M | -55.81%243.04M |
| -Other payable | ---- | ---- | ---- | -4.45%269.29M | ---- | 13.55%275.97M | ---- | -10.49%281.84M | ---- | -55.81%243.04M |
| Non current liabilities due within one year | -11.64%646.22M | 5.01%840.87M | -2.45%723.92M | 25.68%883.6M | 13.08%731.34M | 67.10%800.73M | 79.97%742.08M | 61.58%703.06M | 125.16%646.77M | 66.92%479.19M |
| Other current liabilities | -38.56%1.38M | -49.79%1.38M | -7.59%2.34M | -10.20%2.35M | --2.25M | -29.53%2.74M | --2.53M | --2.62M | ---- | 30.04%3.89M |
| Total current liabilities | 0.28%2.79B | 8.13%3.13B | -4.11%2.83B | -15.68%2.66B | -12.29%2.78B | -14.29%2.89B | 8.26%2.95B | 14.83%3.15B | 35.38%3.17B | 67.50%3.38B |
| Current liabilities | ||||||||||
| Long term loan | 2.74%1.41B | -36.88%877.51M | -13.14%1.11B | -13.57%1.16B | 21.51%1.37B | 17.48%1.39B | 6.69%1.28B | -4.14%1.34B | -33.76%1.13B | -11.16%1.18B |
| Long term account payable | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
| Specific account payable | ---- | ---- | ---- | 6.65%746.93K | ---- | 1.46%350.27K | ---- | 7.94%700.37K | ---- | -62.52%345.22K |
| Deferred tax liabilities | --5.72M | --5.96M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Long term deferred income | -1.53%95.14M | -1.29%96.5M | -2.91%98.44M | -7.44%95.56M | -2.82%96.62M | -1.68%97.75M | 9.07%101.39M | 4.64%103.24M | 8.40%99.43M | 6.67%99.42M |
| Lease liabilities | -10.18%4.27B | -9.05%4.33B | -4.10%4.69B | -2.17%4.72B | -1.03%4.75B | -1.42%4.76B | 8.71%4.89B | 7.59%4.83B | 19.35%4.8B | 29.08%4.83B |
| Other non current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | -44.37%590K | 0.00%590K | 0.00%590K | 0.00%590K |
| Total non current liabilities | -7.10%5.78B | -15.02%5.31B | -5.93%5.91B | -4.70%5.98B | 3.16%6.22B | 2.23%6.25B | 8.30%6.28B | 4.80%6.27B | 3.59%6.03B | 18.28%6.11B |
| Total liabilities | -4.82%8.57B | -7.69%8.44B | -5.35%8.74B | -8.38%8.64B | -2.17%9B | -3.65%9.14B | 8.29%9.23B | 7.96%9.43B | 12.72%9.2B | 32.09%9.49B |
| Shareholders equity | ||||||||||
| Paid-in capital | -0.92%1.25B | -0.92%1.25B | 0.00%1.26B | 0.00%1.26B | 0.00%1.26B | 0.00%1.26B | 0.00%1.26B | 0.00%1.26B | 17.17%1.26B | 17.17%1.26B |
| Other equity instruments | ---- | ---- | ---16.45M | ---9.31M | ---9.31M | ---9.31M | ---- | ---- | ---- | ---- |
| Capital reserve funds | 0.76%2.65B | 0.76%2.65B | 0.00%2.63B | 0.00%2.63B | 0.00%2.63B | 0.00%2.63B | 0.00%2.63B | 0.00%2.63B | 102.41%2.63B | 100.22%2.63B |
| Surplus reserve funds | 0.00%111.67M | 0.00%111.67M | 0.00%111.67M | 0.00%111.67M | 0.00%111.67M | 0.00%111.67M | 0.00%111.67M | 0.00%111.67M | 0.00%111.67M | 0.00%111.67M |
| Retained profit | -133.57%-2.23B | -90.11%-1.85B | 2.47%-985.84M | 26.33%-927.44M | 24.74%-953.05M | 3.89%-972.67M | -81.15%-1.01B | -197.75%-1.26B | -3,892.08%-1.27B | -628.67%-1.01B |
| Shareholders equity without minority interests | -41.27%1.79B | -28.41%2.16B | 0.28%3B | 11.74%3.07B | 11.10%3.04B | 1.00%3.02B | -13.14%2.99B | -23.35%2.75B | 11.46%2.74B | 11.08%2.99B |
| Minority interests | -5.09%188.38M | -8.20%175.42M | -0.43%194.21M | 19.94%215.21M | 23.80%198.48M | 10.17%191.08M | 7.07%195.04M | -6.69%179.42M | -24.03%160.33M | -22.97%173.45M |
| Total shareholder equity | -39.05%1.97B | -27.21%2.34B | 0.24%3.2B | 12.24%3.28B | 11.80%3.24B | 1.51%3.21B | -12.12%3.19B | -22.50%2.92B | 8.65%2.9B | 8.45%3.17B |
| Total liabilityies and equity | -13.88%10.54B | -12.77%10.78B | -3.91%11.94B | -3.49%11.92B | 1.18%12.24B | -2.36%12.36B | 2.20%12.42B | -1.23%12.35B | 11.72%12.1B | 25.26%12.66B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Accounting Firm for the Meeting (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.